Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective.

Patel V, Buckstein M, Perini R, Hill-Kayser C, Svoboda J, Plastaras JP.

Leuk Lymphoma. 2013 Oct;54(10):2168-76. doi: 10.3109/10428194.2013.767902. Epub 2013 Feb 12.

PMID:
23331161
2.

Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.

Picardi M, Pugliese N, Cirillo M, Zeppa P, Cozzolino I, Ciancia G, Pettinato G, Salvatore C, Quintarelli C, Pane F.

Radiology. 2014 Jul;272(1):262-74. doi: 10.1148/radiol.14132154. Epub 2014 Apr 6.

PMID:
24708193
3.

Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.

Dann EJ, Berkahn L, Mashiach T, Frumer M, Agur A, McDiarmid B, Bar-Shalom R, Paltiel O, Goldschmidt N.

Br J Haematol. 2014 Mar;164(5):694-700. doi: 10.1111/bjh.12687. Epub 2013 Dec 7.

PMID:
24313286
4.

Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.

Gandikota N, Hartridge-Lambert S, Migliacci JC, Yahalom J, Portlock CS, Schöder H.

Cancer. 2015 Jun 15;121(12):1985-92. doi: 10.1002/cncr.29277. Epub 2015 Mar 4.

5.

Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.

Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL.

J Clin Oncol. 2012 Jul 20;30(21):2635-40. doi: 10.1200/JCO.2011.40.7841. Epub 2012 Jun 11.

6.

Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.

El-Galaly TC, Mylam KJ, Brown P, Specht L, Christiansen I, Munksgaard L, Johnsen HE, Loft A, Bukh A, Iyer V, Nielsen AL, Hutchings M.

Haematologica. 2012 Jun;97(6):931-6. doi: 10.3324/haematol.2011.056010. Epub 2011 Dec 29.

7.
8.

Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.

Truong Q, Shah N, Knestrick M, Curley B, Hu Y, Craig M, Hamadani M.

Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):50-5. doi: 10.1016/j.clml.2013.08.009. Epub 2013 Oct 10.

PMID:
24119465
9.

Pediatric Hodgkin lymphoma: are we over-scanning our patients?

Rathore N, Eissa HM, Margolin JF, Liu H, Wu MF, Horton T, Kamdar K, Dreyer Z, Steuber P, Rabin KR, Redell M, Allen CE, McClain KL, Guillerman RP, Bollard CM.

Pediatr Hematol Oncol. 2012 Aug;29(5):415-23. doi: 10.3109/08880018.2012.684198. Epub 2012 May 25.

10.

Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?

Eissa HM, Allen CE, Kamdar K, Simko S, Goradia P, Dreyer Z, Steuber P, McClain KL, Guillerman RP, Bollard CM.

Pediatr Hematol Oncol. 2014 Apr;31(3):253-7. doi: 10.3109/08880018.2013.834400. Epub 2013 Oct 2.

11.

Estimated radiation exposure and cancer risk from CT and PET/CT scans in patients with lymphoma.

Guttikonda R, Herts BR, Dong F, Baker ME, Fenner KB, Pohlman B.

Eur J Radiol. 2014 Jun;83(6):1011-1015. doi: 10.1016/j.ejrad.2014.02.015. Epub 2014 Feb 24.

PMID:
24656401
12.

Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center.

El-Galaly T, Prakash V, Christiansen I, Madsen J, Johansen P, Boegsted M, Johnsen HE, Bukh A.

Leuk Lymphoma. 2011 Apr;52(4):597-603. doi: 10.3109/10428194.2010.547642. Epub 2011 Feb 14.

PMID:
21314488
13.

Positron Emission Tomography Scanning in the Management of Hodgkin Lymphoma Patients: A Single-Institution Experience.

Zabrocka E, Sierko E, Wojtukiewicz MZ.

Adv Clin Exp Med. 2016 Nov-Dec;25(6):1185-1192. doi: 10.17219/acem/62652.

14.

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.

Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS.

Cancer. 2014 Jul 15;120(14):2122-9. doi: 10.1002/cncr.28698. Epub 2014 Apr 7.

15.

Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.

Lee AI, Zuckerman DS, Van den Abbeele AD, Aquino SL, Crowley D, Toomey C, Lacasce AS, Feng Y, Neuberg DS, Hochberg EP.

Cancer. 2010 Aug 15;116(16):3835-42. doi: 10.1002/cncr.25240.

16.

Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.

Cerci JJ, Trindade E, Buccheri V, Fanti S, Coutinho AM, Zanoni L, Linardi CC, Celli M, Delbeke D, Pracchia LF, Pitela FA, Soares J Jr, Zinzani PL, Meneghetti JC.

Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):314-20. doi: 10.1016/j.clml.2011.06.006.

PMID:
21816369
17.

Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.

Hiniker SM, Pollom EL, Khodadoust MS, Kozak MM, Xu G, Quon A, Advani RH, Hoppe RT.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):99-106. doi: 10.1016/j.ijrobp.2015.01.039.

PMID:
25863757
18.

18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.

Kahraman D, Theurich S, Rothe A, Kuhnert G, Sasse S, Scheid C, Dietlein M, Drzezga A, von Bergwelt-Baildon M, Kobe C.

Leuk Lymphoma. 2014 Apr;55(4):811-6. doi: 10.3109/10428194.2013.819575. Epub 2013 Jul 29.

PMID:
23805904
19.

Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement.

El-Galaly TC, Hutchings M, Mylam KJ, Brown Pde N, Bukh A, Johnsen HE, Kamper P, Loft A, Iyer V, Gormsen LC, Nielsen AL, Bøgsted M, d'Amore F.

Leuk Lymphoma. 2014 Oct;55(10):2349-55. doi: 10.3109/10428194.2013.875169. Epub 2014 Feb 24.

PMID:
24354682
20.

Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.

Kobe C, Kuhnert G, Kahraman D, Haverkamp H, Eich HT, Franke M, Persigehl T, Klutmann S, Amthauer H, Bockisch A, Kluge R, Wolf HH, Maintz D, Fuchs M, Borchmann P, Diehl V, Drzezga A, Engert A, Dietlein M.

J Clin Oncol. 2014 Jun 10;32(17):1776-81. doi: 10.1200/JCO.2013.53.2507. Epub 2014 May 5.

PMID:
24799482

Supplemental Content

Support Center